# Efficacy and Safety of Sacubitril/Valsartan in Maintenance Hemodialysis Patients With Heart Failure

> **NCT04458285** · NA · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 118 (estimated)

## Conditions studied

- Hemodialysis Complication
- Heart Failure

## Interventions

- **DRUG:** Sacubitril / Valsartan Oral Tablet [Entresto]
- **DRUG:** Valsartan 80mg Tablet

## Key facts

- **NCT ID:** NCT04458285
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04458285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04458285, "Efficacy and Safety of Sacubitril/Valsartan in Maintenance Hemodialysis Patients With Heart Failure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04458285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*